upcomingGrant
Small molecule high throughput screen using AstraZeneca facilities
Executive Summary
This opportunity provides researchers and SMEs with unique access to AstraZeneca’s proprietary compound libraries and high-throughput screening infrastructure to accelerate early-stage drug discovery. It is a high-value proposition for organizations looking to leverage industrial-scale automation for small molecule development.
Expected Launch
September 2026
Funding Body
Innovate UK
Eligible Applicants
SME, Large, RTO, Academic, Charity
Funding Available & Project Rates
£1 million total fund with a maximum award of £270,000 per project.
Official PortalView Competition Brief
Target Sectors
biotechnologyhealthcare
Technology Scope
small molecule discoveryhigh throughput screeningdrug discoveryautomationrobotics
Ready to Apply?
Draft This Application with ZenGrants
Accelerate your application prep with ZenGrants AI discovery, sector research, and assessor-aligned proposal drafting for Small molecule high throughput screen using AstraZeneca facilities.
Competition Scope & Overview
Apply for funding to run a high throughput screen using AstraZeneca’s compound library and screening robots.